Institutional investors hold a majority ownership of AMGN through the 83.41% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2014, these large investors purchased a net $1.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE STREET GLOBAL ADVISORS LTD... Bought 169.6 Thousand shares of Amgen
CANDRIAM BELGIUM SA Bought 109.5 Thousand shares of Amgen
NEWMAN DIGNAN & SHEERAR, INC. Bought 93.6 Thousand shares of Amgen